Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatology Practical & Conceptual, [S. l.], v. 13, n. 4, p. e2023215, 2023. DOI: 10.5826/dpc.1304a215. Disponível em: https://dpcj.org/index.php/dpc/article/view/3114.. Acesso em: 6 dec. 2024.